Category Archives: DTC Advertising

Perspectives on DTC Perspectives

Yesterday I had the good fortune to participate on a panel staged at the National DTC Perspectives Conference held here in Washington.   The conference was impressive not only because of the size and scope of the turnout – hundreds … Continue reading

Posted in DTC Advertising, FDA Policy | 2 Comments

FDA Staffing Provides Insight into Future Changes Affecting DTC

This week it was announced that a senior fellow from the office of Senator Edward Kennedy would be heading back to FDA as a senior counselor to Dr. Joshua Sharfstein where it is reported that the FDA Office of Legislative … Continue reading

Posted in DTC Advertising, FDA Policy | Comments Off on FDA Staffing Provides Insight into Future Changes Affecting DTC

DTC in the Crosshairs of Congressman Waxman

Reuters carried a report yesterday confirming not only that a moratorium on Direct-to-Consumer (DTC) advertising is likely to be introduced in the next Congress, but is going to be broached by Congressman Henry Waxman, the new Chair of the House … Continue reading

Posted in DTC Advertising | 1 Comment

Change is in the Air

Yesterday I gave a brief talk at the DTC Perspectives conference held in New Jersey called DTC in the Era of Consumer Choice.  I thought I’d outline a few of my thoughts on the future of DTC here as well. … Continue reading

Posted in DTC Advertising | 2 Comments

Rule by Committee – Curbing DTC Advertisting by Pharmas – Enough to Stave Off Reforms?

Advertising Age carried a June 16 story regarding an agreement by several pharmaceutical manufacturers to curb DTC advertising.  Here is a bit of the history of this agreement according to the Energy and Commerce Web site.  Early this year, Representatives … Continue reading

Posted in DTC Advertising | Comments Off on Rule by Committee – Curbing DTC Advertisting by Pharmas – Enough to Stave Off Reforms?